Your browser doesn't support javascript.
loading
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Jacquelot, Nicolas; Seillet, Cyril; Wang, Minyu; Pizzolla, Angela; Liao, Yang; Hediyeh-Zadeh, Soroor; Grisaru-Tal, Sharon; Louis, Cynthia; Huang, Qiutong; Schreuder, Jaring; Souza-Fonseca-Guimaraes, Fernando; de Graaf, Carolyn A; Thia, Kevin; Macdonald, Sean; Camilleri, Mary; Luong, Kylie; Zhang, Shengbo; Chopin, Michael; Molden-Hauer, Tristan; Nutt, Stephen L; Umansky, Viktor; Ciric, Bogoljub; Groom, Joanna R; Foster, Paul S; Hansbro, Philip M; McKenzie, Andrew N J; Gray, Daniel H D; Behren, Andreas; Cebon, Jonathan; Vivier, Eric; Wicks, Ian P; Trapani, Joseph A; Munitz, Ariel; Davis, Melissa J; Shi, Wei; Neeson, Paul J; Belz, Gabrielle T.
Afiliação
  • Jacquelot N; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. nicolas.jacquelot@uhnresearch.ca.
  • Seillet C; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. nicolas.jacquelot@uhnresearch.ca.
  • Wang M; Princess Margaret Cancer Centre, Toronto, Ontario, Canada. nicolas.jacquelot@uhnresearch.ca.
  • Pizzolla A; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Liao Y; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Hediyeh-Zadeh S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Grisaru-Tal S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Louis C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Huang Q; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Schreuder J; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Souza-Fonseca-Guimaraes F; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • de Graaf CA; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
  • Thia K; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria, Australia.
  • Macdonald S; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Camilleri M; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Luong K; Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Zhang S; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Chopin M; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Molden-Hauer T; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Nutt SL; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Umansky V; The University of Queensland Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.
  • Ciric B; The University of Queensland Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.
  • Groom JR; The University of Queensland Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.
  • Foster PS; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Hansbro PM; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • McKenzie ANJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Gray DHD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Behren A; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Cebon J; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Vivier E; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Wicks IP; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Trapani JA; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Munitz A; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Davis MJ; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Shi W; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Belz GT; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
Nat Immunol ; 22(7): 851-864, 2021 07.
Article em En | MEDLINE | ID: mdl-34099918

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Experimental / Linfócitos / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor de Morte Celular Programada 1 / Interleucina-33 / Inibidores de Checkpoint Imunológico / Anticorpos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Experimental / Linfócitos / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor de Morte Celular Programada 1 / Interleucina-33 / Inibidores de Checkpoint Imunológico / Anticorpos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos